Author Correction: ROR1 is upregulated in endometrial cancer and represents a novel therapeutic target

被引：0
|
作者：
Dongli Liu
Kate Gunther
Luis A. Enriquez
Benjamin Daniels
Tracy A. O’Mara
Katrina Tang
Amanda B. Spurdle
Caroline E. Ford
机构：
[1] University of New South Wales,Gynaecological Cancer Research Group, Lowy Cancer Research Centre, School of Women’s and Children’s Health, Faculty of Medicine
[2] University of New South Wales,Medicines Policy Research Unit, Centre for Big Data Research in Health, Faculty of Medicine
[3] QIMR Berghofer Medical Research Institute,South Eastern Area Laboratory Services Pathology
[4] Prince of Wales Hospital,undefined
来源：
Scientific Reports | / 12卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] ROR-γ drives androgen receptor expression and represents a therapeutic target in castration-resistant prostate cancer
    Junjian Wang
    June X Zou
    Xiaoqian Xue
    Demin Cai
    Yan Zhang
    Zhijian Duan
    Qiuping Xiang
    Joy C Yang
    Maggie C Louie
    Alexander D Borowsky
    Allen C Gao
    Christopher P Evans
    Kit S Lam
    Jianzhen Xu
    Hsing-Jien Kung
    Ronald M Evans
    Yong Xu
    Hong-Wu Chen
    [J]. Nature Medicine, 2016, 22 : 488 - 496
  • [32] ROR1 is a novel prognostic biomarker in patients with lung adenocarcinoma
    Zheng, Yu-Zhu
    Ma, Rui
    Zhou, Jian-Kang
    Guo, Cheng-Lin
    Wang, Yong-Sheng
    Li, Zheng-Guang
    Liu, Lun-Xu
    Peng, Yong
    [J]. SCIENTIFIC REPORTS, 2016, 6
  • [33] Acidic microenvironments drive cancer metastasis through ROR1
    不详
    [J]. JOURNAL OF CELL SCIENCE, 2021, 134 (07)
  • [34] Ror2 as a Therapeutic Target in Cancer
    Debebe, Zufan
    Rathmell, W. Kimryn
    [J]. PHARMACOLOGY & THERAPEUTICS, 2015, 150 : 143 - 148
  • [35] ROR1 MRNA EXPRESSION IN GLIOMA - A NOVEL PROGNOSTIC BIOMARKER
    Madani, Daniel
    John, Miya
    Satgunaseelan, Laveniya
    Shivalingam, Brindha
    Ford, Caroline
    [J]. NEURO-ONCOLOGY, 2022, 24 : 6 - 6
  • [36] The onco-embryonic antigen ROR1 is a target of chimeric antigen T cells for colorectal cancer
    Meng, Shangsen
    Li, Ming
    Qin, Le
    Lv, Jiang
    Wu, Di
    Zheng, Diwei
    Jia, Heng
    Chen, Dongmei
    Wu, Qiting
    Long, Youguo
    Tang, Zhaoyang
    Tang, Yanlai
    Yang, Lihua
    Yao, Yao
    Luo, Xuequn
    Li, Peng
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 121
  • [37] ROR1 is a novel prognostic biomarker in patients with lung adenocarcinoma
    Yu-Zhu Zheng
    Rui Ma
    Jian-Kang Zhou
    Cheng-Lin Guo
    Yong-Sheng Wang
    Zheng-Guang Li
    Lun-Xu Liu
    Yong Peng
    [J]. Scientific Reports, 6
  • [38] ROR1 is associated with ovarian cancer progression and chemoresistance.
    Liu, Dongli
    John, Miya
    Henry, Claire E.
    Christie, Elizabeth L.
    Bowtell, David D. L.
    Tang, Kristina
    Heinzelmann-Schwarz, Viola
    Kennedy, Catherine
    Boros, Jessica
    DeFazio, Anna
    Ford, Caroline E.
    [J]. CLINICAL CANCER RESEARCH, 2020, 26 (13) : 59 - 60
  • [39] ROR1 AS A NOVEL THERAPEUTIC TARGET FOR EGFR-MUTANT NON-SMALL-CELL LUNG CANCER (NSCLC) PATIENTS WITH THE EGFR T790M MUTATION
    Karachaliou, Niki
    Drozdowskyj, Ana
    Costa, Carlota
    Angel Molina-Vila, Miguel
    Gimenez-Capitan, Ana
    Vergnenegre, Alain
    Massuti, Bartomeu
    Moran, Teresa
    Majem, Margarita
    Felip, Enriqueta
    Carcereny, Enric
    Garcia-Campelo, Rosario
    Viteri, Santiago
    Heidecke, Cordula
    Estrada-Tejedor, Roger
    Teixido, Jordi
    Bivona, Trever
    Giannikopoulos, Petros
    Ono, Mayumi
    Rosell, Rafael
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1048 - S1048
  • [40] ROR1, an embryonic protein with an emerging role in cancer biology
    Nicholas Borcherding
    David Kusner
    GuangHui Liu
    Weizhou Zhang
    [J]. Protein & Cell, 2014, 5 (07) : 496 - 502
12345